E-DRUG: The burden of bacterial antimicrobial resistance in the WHO African
region in 2019
https://www.thelancet.com/action/showPdf?pii=S2214-109X(23)00539-9
The burden of bacterial antimicrobial resistance in the WHO African region
in 2019: a cross-country systematic analysis Antimicrobial Resistance
Collaborators* Summary Background A critical and persistent challenge to
global health and modern health care is the threat of antimicrobial
resistance (AMR). Previous studies have reported a disproportionate burden
of AMR in low-income and middle[1]income countries, but there remains an
urgent need for more in-depth analyses across Africa. This study presents
one of the most comprehensive sets of regional and country-level estimates
of bacterial AMR burden in the WHO African region to date
[Third-generation cephalosporin-resistant K pneumoniae and
meticillinresistant S aureus were shown to be the leading pathogen-drug
combinations in 25 and 16 countries, respectively (53% and 34% of the whole
region, comprising 47 countries) for deaths attributable to AMR.
[thanks to Lucas for tipping us!]